Renalytix PLC
LSE:RENX
Operating Margin
Renalytix PLC
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | UK |
Market Cap | 29m GBP |
Operating Margin |
-1 245%
|
Country | US |
Market Cap | 34.1B USD |
Operating Margin |
18%
|
Country | US |
Market Cap | 27.9B USD |
Operating Margin |
13%
|
Country | US |
Market Cap | 9B USD |
Operating Margin |
3%
|
Country | AU |
Market Cap | 12.5B AUD |
Operating Margin |
69%
|
Country | JP |
Market Cap | 1.1T JPY |
Operating Margin |
26%
|
Country | US |
Market Cap | 4.7B USD |
Operating Margin |
-5%
|
Country | US |
Market Cap | 4.4B USD |
Operating Margin |
35%
|
Country | SE |
Market Cap | 45.5B SEK |
Operating Margin |
-39%
|
Country | US |
Market Cap | 2.8B USD |
Operating Margin |
0%
|
Country | US |
Market Cap | 2.7B USD |
Operating Margin |
-4%
|
Profitability Report
View the profitability report to see the full profitability analysis for Renalytix PLC.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Renalytix PLC's most recent financial statements, the company has Operating Margin of -1 244.6%.